About Event

What’s On?

With 800+ mRNA drug candidates in development, over 65% still remain in pre-clinical proof-of-concept stages and the field is beelining towards the first clinical approval beyond infectious disease.

The 3rd mRNA-Based Therapeutics Summit Europe returned to Berlin as the European mRNA community’s most comprehensive forum, to provide a clear strategy and roadmap towards clinical success and regulatory approval, delivering the promise of better mRNA medicines to patients faster.

What You Missed:

  • Recognising Key Regulatory Considerations for mRNA Applications & Use of mRNA-LNP Technology with the MHRA’s perspective
  • Showcasing WHO’s mRNA Vaccine R&D Priorities & Requirements for Low- & Middle- Income Countries
  • Delivery of mRNA Therapeutics for Treatment of Respiratory, Chronic Kidney & Cardiovascular Diseases with Ethris, Pantherna Therapeutics, Mercurna and Elastrin Therapeutics

You Missed Out On:

90%

Of the Speaker Faculty NEW for 2024

4

Interactive Panel Discussions

200+

mRNA-Focused Attendees

1

AI RNA Design & Discovery Focus Day

50+

World-Class Speakers

1

CEO & Future Leaders' Fireside Chat

10+

Hours of Dedicated Networking

2023 Event Highlights

Speaking Companies New in 2024:

speakers banner